Movicol and Inappropriate antidiuretic hormone secretion - a phase IV clinical study of FDA data

Summary:

Inappropriate antidiuretic hormone secretion is reported as a side effect among people who take Movicol (polyethylene glycol 3350), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Remeron, and have Depression.

The phase IV clinical study analyzes which people have Inappropriate antidiuretic hormone secretion when taking Movicol. It is created by eHealthMe based on reports of 14,199 people who have side effects when taking Movicol from the FDA, and is updated regularly.

What is Movicol?

Movicol has active ingredients of polyethylene glycol 3350. It is often used in constipation. eHealthMe is studying from 14,249 Movicol users. Check the latest studies of Movicol.

What is Inappropriate antidiuretic hormone secretion?

Inappropriate antidiuretic hormone secretion is found to be associated with 666 drugs and 1,039 conditions by eHealthMe. Check the latest studies of Inappropriate antidiuretic hormone secretion.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

14,199 people reported to have side effects when taking Movicol.
Among them, 37 people (0.26%) have Inappropriate antidiuretic hormone secretion.

Could Movicol cause Inappropriate antidiuretic hormone secretion?

Among these 37 people:

How long have people been on Movicol when they have Inappropriate antidiuretic hormone secretion? *

What is the gender of people who have Inappropriate antidiuretic hormone secretion when taking Movicol? *

female: 75 %
male: 25 %

What is the age of people who have Inappropriate antidiuretic hormone secretion when taking Movicol? *

What are other drugs people take besides Movicol? *

What are other side effects people have besides Inappropriate antidiuretic hormone secretion? *

Hyponatremia (abnormally low level of sodium in the blood; associated with dehydration): 21 people, 56.76%
Fall: 9 people, 24.32%
Dementia (madness): 4 people, 10.81%
Bladder Dilatation: 4 people, 10.81%
Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down): 4 people, 10.81%
Nausea And Vomiting: 4 people, 10.81%
Hospitalisation: 3 people, 8.11%
Urinary Retention (the inability to completely or partially empty the bladder): 3 people, 8.11%
Blood Sodium Decreased: 3 people, 8.11%
Neuropathy Peripheral (surface nerve damage): 3 people, 8.11%

What are the existing conditions these people have? *

Depression: 14 people, 37.84%
High Blood Pressure: 11 people, 29.73%
Insomnia (sleeplessness): 5 people, 13.51%
High Blood Cholesterol: 5 people, 13.51%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 5 people, 13.51%
Bipolar Disorder (mood disorder): 4 people, 10.81%
Cardiac Failure: 3 people, 8.11%
Multiple Myeloma (cancer of the plasma cells): 3 people, 8.11%
Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 2 people, 5.41%
Polyarthritis (arthritis which involves 5 or more joints simultaneously): 2 people, 5.41%

* Approximation only. Some reports may have incomplete information.

Do you take Movicol and have Inappropriate antidiuretic hormone secretion?

- Check whether Inappropriate antidiuretic hormone secretion is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Movicol:

Movicol (14,249 reports)

Inappropriate antidiuretic hormone secretion treatments and more:

Inappropriate antidiuretic hormone secretion (11,995 reports)

How severe was Inappropriate antidiuretic hormone secretion and when was it recovered:

Inappropriate antidiuretic hormone secretion in Movicol

Expand to all the drugs that have ingredients of polyethylene glycol 3350:

Inappropriate antidiuretic hormone secretion and drugs with ingredients of polyethylene glycol 3350 (93 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Movicol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Inappropriate antidiuretic hormone secretion:

Inappropriate antidiuretic hormone secretion (666 drugs)

Browse all the conditions that are associated with Inappropriate antidiuretic hormone secretion:

Inappropriate antidiuretic hormone secretion (1,039 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on polyethylene glycol 3350 (the active ingredients of Movicol) and Movicol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.